Littelfuse, Inc. (LFUS) Tops Q3 EPS by 1c; Issues Q4 Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts LFUS Hot Sheet
Price: $425.88 -2.04%
Revenue Growth %: +15.7%
Financial Fact:
Research and development expenses: 10.4M
Today's EPS Names:
PKE, BYRN, HELE, More
Revenue Growth %: +15.7%
Financial Fact:
Research and development expenses: 10.4M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Littelfuse, Inc. (NASDAQ: LFUS) reported Q3 EPS of $1.08, $0.01 better than the analyst estimate of $1.07. Revenue for the quarter came in at $172.7 million versus the consensus estimate of $175.42 million.
Littelfuse, Inc. sees Q4 2012 EPS of $0.75-0.90, versus the consensus of $0.95. Littelfuse, Inc. sees Q4 2012 revenue of $152-162 million, versus the consensus of $166.74 million.
For earnings history and earnings-related data on Littelfuse, Inc. (LFUS) click here.
Littelfuse, Inc. sees Q4 2012 EPS of $0.75-0.90, versus the consensus of $0.95. Littelfuse, Inc. sees Q4 2012 revenue of $152-162 million, versus the consensus of $166.74 million.
For earnings history and earnings-related data on Littelfuse, Inc. (LFUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- AngioDynamics (ANGO) Tops Q1 EPS by 7c, Beats on Revenue; Offers F27 Revenue Guidance
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
